CBI arrests Joints Drug Controller of CDSCO, aide in bribery case

by IANS |

New Delhi, June 21 (IANS) The Central Bureau of Investigation (CBI) has said that they have apprehended a Joint Drug Controller (JDC) of Central Drugs Standard Control Organisation (CDSCO) and the Director of a private company for allegedly demanding bribe to waive the Phase-3 trial of "Insulin Aspart Injection".

The accused JDC identified as E. Eswara Reddy posted with CDSCO headquarters, New Delhi, while his aide was identified as Dinesh Dua, the Director of Delhi-based Synergy Network India Private Limited.

A senior CBI official said that a case was lodged against Reddy, Dua and others which includes Guljit Sethi, the Director of Bioinnovat Research Service Private Limited; L. Praveen Kumar, the Associate Voice President and Head of National Regulatory Affairs of Biocon Biologics Limited; Animesh Kumar, the Assistant Drug Inspector of CDSCO and others.

"It was alleged that Reddy was trying to exert undue influence on officers of CDSCO to waive the Phase-3 trial of "Insulin Aspart Injection". The accused agreed to pay bribe amount of Rs 9 lakh to Reddy for favourably processing the said three files related to Banglore-based Biocon Biologics Limited and also for favourably recommending the file of "Insulin Aspart injection" to the Subject Expert Committee meeting.

The CBI laid a trap wherein Reddy was caught while accepting a bribe of Rs 4 lakh from Dua.

The CBI also conducted searches at 11 locations in Delhi, Noida, Gurugram, Patna, Bengaluru which led to the recovery of incriminating documents.

Meanwhile, the Biocon Biologics issued a ststement saying their Aspart was approved in Europe and many other countries.

"We deny few allegations reported in India. All our product approvals are legitimate and backed by science and clinical data. Our Aspart is approved in Europe and many other countries. We follow due regulatory process for all our product approvals by DCGI. The entire application process in India is online and all meeting minutes are in public domain. We are co-operating with the investigation agency," said Biocon Biologics in a press release.

Further investigation in the matter is underway.

Latest News
ENG v IND, 5th Test: No better person to take over after me than Rahul, says Ravi Shastri Sun, Jul 03, 2022, 04:53 PM
Oppn unity could stymie BJP's aggressive Hindutva push in K'taka Sun, Jul 03, 2022, 04:24 PM
Maha Speaker, BJP's Rahul Narwekar is India's youngest in the august seat Sun, Jul 03, 2022, 03:50 PM
On another day one of those edges would have gone straight to a fielder: Anderson on Broad's expensive over Sun, Jul 03, 2022, 03:46 PM
Losing opportunities: Oppn needs to get its act together Sun, Jul 03, 2022, 03:41 PM
Apple captures half of all smartphones sold during Chinese online fest Sun, Jul 03, 2022, 03:22 PM
Crypto broker Voyager suspends all trading, withdrawals, deposits Sun, Jul 03, 2022, 03:17 PM
S.Korea's new Covid cases stay over 10,000 amid resurgence woes Sun, Jul 03, 2022, 03:01 PM
West Indies great Lara congratulates Bumrah after Indian breaks his record Sun, Jul 03, 2022, 03:00 PM
BJP's Urdu counter to Gujarati tweets by TRS Sun, Jul 03, 2022, 02:51 PM
PM lauds Murmu's candidature, says it stands over and above any politics Sun, Jul 03, 2022, 02:37 PM
Telangana intelligence officer 'caught' during BJP national executive meet Sun, Jul 03, 2022, 02:08 PM
Will take confidence from India's fight-back: Anderson Sun, Jul 03, 2022, 02:06 PM
Large borrowers' loan accounts and bad loans decline: RBI Sat, Jul 02, 2022, 03:53 PM
Top crypto hedge fund Three Arrows Capital files for bankruptcy Sat, Jul 02, 2022, 03:52 PM